Erratum

Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

Y. H. Ling, T. Li, Z. Yuan, Missak Haigentz, T. K. Weber, R. Perez-Soler

Research output: Contribution to journal › Comment/debate

Original languageEnglish (US)
Number of pages1
JournalMolecular Pharmacology
Volume88
Issue number2
DOIs
StatePublished - Aug 1 2015

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Ling, Y. H. ; Li, T. ; Yuan, Z. ; Haigentz, Missak ; Weber, T. K. ; Perez-Soler, R. / Erratum : Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). In: Molecular Pharmacology. 2015 ; Vol. 88, No. 2.
@article{b129bd26d33f46a5b76bcf8593e3d1bc,
title = "Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)",
author = "Ling, {Y. H.} and T. Li and Z. Yuan and Missak Haigentz and Weber, {T. K.} and R. Perez-Soler",
year = "2015",
month = "8",
day = "1",
doi = "10.1124/mol.115.08er15a",
language = "English (US)",
volume = "88",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

Ling, YH, Li, T, Yuan, Z, Haigentz, M, Weber, TK & Perez-Soler, R 2015, 'Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)', Molecular Pharmacology, vol. 88, no. 2. https://doi.org/10.1124/mol.115.08er15a

Erratum : Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). / Ling, Y. H.; Li, T.; Yuan, Z.; Haigentz, Missak; Weber, T. K.; Perez-Soler, R.

In: Molecular Pharmacology, Vol. 88, No. 2, 01.08.2015.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827)

AU - Ling, Y. H.

AU - Li, T.

AU - Yuan, Z.

AU - Haigentz, Missak

AU - Weber, T. K.

AU - Perez-Soler, R.

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84939785782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939785782&partnerID=8YFLogxK

U2 - 10.1124/mol.115.08er15a

DO - 10.1124/mol.115.08er15a

M3 - Comment/debate

VL - 88

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -

Ling YH, Li T, Yuan Z, Haigentz M, Weber TK, Perez-Soler R. Erratum: Erlotinib, An effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines (Mol Pharmacol (2007) 72 (248-258) DOI: 10.1124/mol.107.034827). Molecular Pharmacology. 2015 Aug 1;88(2). https://doi.org/10.1124/mol.115.08er15a

Access to Document